Foldax closes US$20 million financing

Foldax has announced the closing of a $20 million Series D round of funding. According to a press release, MemorialCare Innovation Fund (MCIF) led the round, with Angel Physicians Fund (APF) and Sayan Bioventures joining as new investors. All existing investors also participated in the round, including BioStar Capital, Kairos Ventures and Caltech. Brant [...]

2020-06-23T11:23:10+00:00June 23rd, 2020|Tags: , , , , |

Rexgenero acquires assets of aratinga.bio SAS Group

A press release reports that Rexgenero has acquired all the key technology and program assets of aratinga.bio SAS Group. It adds that the acquisition, which follows the recent approval by the French Commercial Court, includes all patent applications and related intellectual property, the exclusive license agreement for polymeric nanoparticle technology and the bioproduction facilities [...]

2020-06-23T11:17:08+00:00June 23rd, 2020|Tags: , , |

Vaseem Mahboob steps down as CFO of Endologix

Endologix has announced that Vaseem Mahboob, chief financial officer (CFO), will be departing the company effective 1 July 2020 to become CFO of a private global healthcare company. Cindy Pinto, vice president, Financial Planning & Analysis, will assume the role of interim CFO in addition to her current responsibilities, and Endologix has initiated a [...]

2020-06-19T11:32:45+00:00June 19th, 2020|Tags: , |

Cook Medical and Surmodics reach distribution agreement for two new vascular products

Cook Medical and Surmodics have announced an agreement in which Cook Medical will distribute two new Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that can be used over 0.014-inch and a 0.018-inch wire guides. “We have had a long relationship with Surmodics, utilising its innovative surface modification technology with many of our [...]

2020-05-11T15:49:16+00:00May 11th, 2020|Tags: , , |

Abiomed acquires novel ECMO developer Breethe

Abiomed (maker of the Impella heart pump) has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system. A press release reports that the acquisition will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation. Such patients include those with cardiogenic [...]

2020-05-01T13:18:09+00:00May 1st, 2020|Tags: , , , |

Artio Medical appoints Nathaniel Hagedorn to board of directors

Nathaniel Hagedorn Artio Medical has announced the appointment of entrepreneur and businessman Nathaniel Hagedorn to its board of directors. As the founder and CEO of NorthPoint Development, Hagedorn has raised over $6.5B in capital and brings nearly two decades of experience in accessing new markets and scaling new business opportunities. Hagedorn founded [...]

2020-05-01T12:25:25+00:00May 1st, 2020|Tags: , , |

Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

Acurate neo (first generation) Boston Scientific, according to a press release announcing the company’s Q1 2020 financial results, has received the CE mark for its Acurate neo2 aortic valve system. The press release reports that the transcatheter aortic valve implantation (TAVI) system builds on the clinical performance of the original Acurate neo [...]

2020-05-01T10:27:58+00:00May 1st, 2020|Tags: , , , |

Cardiovascular robotics company secures €40 million series C financing round

Robocath, which designs, develops and commercialises cardiovascular robotic systems for the treatment of vascular diseases, has secured €40 million ($43M) in a series C round of financing. A press release reports that this was led by MicroPort Scientific Corporation, with participation from institutional investors (Zhejiang Silk Road Fund, Luxembourg CLIIF managed under TUS-Holdings, CS [...]

2020-05-01T10:24:07+00:00May 1st, 2020|Tags: , , |

Proximo Medical named as commercialisation partner for Elucid Bioimaging

Elucid Bioimaging Proximo Medical has announced a partnership with Elucid Bioimaging, a developer of diagnostic image analysis software used to assist in the detection and treatment of myocardial infarction and stroke. A press release states that Elucid Bioimaging’s signature technology, vascuCAP, is the only Food and Drug Administration (FDA)-cleared, histologically-validated software for [...]

2020-04-22T12:29:23+00:00April 22nd, 2020|Tags: , , |

MolecuLight announces strategic alliance with Tissue Analytics

i:X MolecuLight has announced the integration of its MolecuLight i:X device with Tissue Analytics’ interconnected platform for seamless integration with leading electronic medical record (EMR)/electronic health record (EHR) platforms. According to a press release, Tissue Analytics is an artificial intelligence (AI)-powered cloud-based software solution that allows providers to monitor and automatically measure [...]

2020-04-16T15:33:00+00:00April 16th, 2020|Tags: , , |

OrthoPediatrics buys ApiFix Ltd, developer of FDA-approved non-fusion scoliosis technology

OrthoPediatrics has acquired ApiFix, including its minimally invasive deformity correction (MID-C) system for non-fusion treatment of progressive adolescent idiopathic scoliosis, for 934,768 shares of OrthoPediatrics common stock and US$2 million in cash paid at closing, plus milestone payments and an earnout over a period of four years. A press release reports that ApiFix is [...]

2020-04-06T10:07:53+00:00April 6th, 2020|Tags: , , , |

COVID-19: Boston Scientific takes steps to mitigate impact of pandemic

Boston Scientific has revealed that its assuming the Q2 2020 impact of COVID-19 will be more significant than that of Q1 2020. As a result, the company is “taking proactive steps to reduce costs and be in a strong position to support customers and patients when healthcare systems begin to recover, and elective procedures [...]

2020-04-02T16:24:12+00:00April 2nd, 2020|Tags: , , |

Artio Medical Closes $8.8 million of additional dinancing

Artio Medical, a medical device company developing innovative products for the peripheral vascular and neurovascular markets, has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million. The additional funds will help Artio obtain 510(k) marketing clearance from the FDA to market the [...]

2020-04-01T16:06:12+00:00April 1st, 2020|Tags: , |

ATEC agrees to acquire EOS imaging

EOSedge Alphatec Holdings (ATEC) has announced that it has entered into an agreement to acquire EOS imaging for a purchase price of up to US$88 million, plus debt retirement of US$33.9 million, in a combination of cash and equity. EOS imaging is specialist in orthopaedic medical imaging and software solutions. The EOS technology [...]

2020-03-05T11:09:44+00:00March 5th, 2020|Tags: , , , |

Medtronic acquires UK company Digital Surgery

Medtronic has announced its acquisition of Digital Surgery, which is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. A press release says that the acquisition will strengthen the Medtronic robotic-assisted surgery platform and has applicability for the Medtronic broader portfolio. The terms of the agreement have [...]

2020-02-17T13:49:00+00:00February 17th, 2020|Tags: , , , |

Rexgenero appoints Huw Jones as a non-executive director

Huw Jones Rexgenero has announced that Huw Jones has joined the company’s board as a non-executive director, and will chair the company’s remuneration committee. This follows the recent appointment of David Horn Solomon as chairman of Rexgenero’s Board. Huw is currently CEO of Chronos Therapeutics Limited (Chronos), a spin out from the [...]

2020-02-17T13:39:13+00:00February 17th, 2020|Tags: , |

CorWave appoints Jim Schuermann as an independent director

CorWave, a medtech company focused on the development of an innovative left ventricular assist device (LVAD), has announced today the election of Jim Schuermann to its board of directors. A press release states that Schuermann was instrumental in transforming HeartWare—a LVAD start-up valued around $100M when he joined—into a $Bn Nasdaq-listed company. As senior [...]

2020-02-17T13:33:23+00:00February 17th, 2020|Tags: , , |

Metactive Medical changes name to “Artio Medical”

Metactive Medical has changed its name to Artio Medical, effective immediately. Artio Medical was founded in 2014 as a small research and development group focused on developing metal implants for vascular embolisation. The organisation has since grown to include a team, according to a press release, of exceptionally talented medical device professionals and expanded [...]

2020-02-17T13:13:26+00:00February 17th, 2020|Tags: , |

Rhythm AI to work with Biosense Webster on STAR Mapping clinical trial

Rhythm AI has announced the signing of a research collaboration agreement with Biosense Webster. A press release outlines that the agreement grants Rhythm AI access to certain data from the Biosense Webster CARTO 3 system to support a multicentre clinical trial of its STAR Mapping system. STAR Mapping is a new, AI driven mapping [...]

2020-02-05T13:15:09+00:00February 5th, 2020|Tags: , , , |

Biolitec adds new laser fibre for severely tortuous veins to its portfolio

ELVes Radial 2ring Pro fibre Biolitec has added another laser fibre to its ELVeS Radial 2ring laser fibre portfolio. A press release reports that the newly developed ELVeS Radial 2ring Pro enables the minimally invasive endovenous laser treatment of severely tortuous veins. It adds that the ELVeS Radial 2ring Pro fibre has [...]

2020-02-05T12:49:04+00:00February 5th, 2020|Tags: , , |

Admedus finalises license and associated milestone payment with 4C Medical

Admedus has announced the complete transfer of its sterilisation method as part of its Adapt tissue treatment process to 4C Medical. As per the Admedus supply agreement with 4C Medical, 4C Medical will pay an additional $US1 Million ($US 0.44M previously received) to use the technology to sterilise the Adapt tissue incorporated in its transcatheter [...]

2020-02-05T12:30:37+00:00February 5th, 2020|Tags: , , , |

Vascular Therapies complete upsized $17.3m private financing

Vascular Therapies has announced the closing of an upsized $17.3 million private financing. A press release reports that the financing comprised existing and new investors, and was increased from an originally targeted $15 million up to $17.3 million—based upon interest from new investors, including a strategic foreign healthcare company. It adds that Vascular Therapies [...]

2020-01-31T10:05:33+00:00January 31st, 2020|Tags: , , |

David Hayes appointed as chief medical officer of Biotronik

David Hayes Biotronik has announced the appointment of David Hayes as chief medical officer. A press release reports that Hayes will oversee the development of the company’s cardiovascular solutions with a focus on advancing unique, proven innovations that help physicians and health systems deliver on their commitment to patient care. The press [...]

2020-02-03T10:03:58+00:00January 28th, 2020|Tags: , |

Cagent Vascular initiates enrolment of PRELUDE-BTK study using Serranator device

Cagent Vascular has announced the initiation of the PRELUDE-BTK study. According to a press release, the purpose of this prospective, single-arm, multicentre feasibility study is to show the safety and efficacy of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter in infrapopliteal arteries. Andrew Holden (University of Auckland, Auckland Hospital, Auckland, New Zealand) [...]

2020-01-15T15:40:29+00:00January 15th, 2020|Tags: , , |

Medtronic acquires pioneer of a novel spinal cord stimulation waveform

Intellis Medtronic has acquired Stimgenics, which a press release reports has pioneered a novel spinal cord stimulation (SCS) waveform known as “differential target multiplexed” (DTM) spinal cord stimulation. The press release adds that the therapy, which is delivered via the Medtronic Intellis platform, is a new and unique programming option to treat [...]

2020-01-15T15:26:39+00:00January 15th, 2020|Tags: , , , |

Titan Medical and Cambridge design partnership announce expanded engagement for robotic instrument development

Titan Medical and Cambridge Design Partnership (CDP) has announced an expanded engagement in respect of the instrument development programme for Titan’s single-port robotic surgical system. Additionally, CDP has subscribed for common shares of Titan. David McNally, president and CEO of Titan, says: “We are pleased to announce our expanded engagement of CDP, and welcome [...]

2020-01-15T15:11:00+00:00January 15th, 2020|Tags: , , |

TriSalus Life Sciences launches TriNav infusion system

TriNav TriSalus Life Sciences has launched its TriNav infusion system (TriNav). Powered by its proprietary pressure-enabled drug delivery (PEDD) approach with SmartValve technology, according to a press release, TriNav is designed to help overcome the infusion barriers that limit therapeutic uptake in solid tumours, including hepatocellular carcinoma and liver metastases. The press [...]

2020-01-15T15:05:32+00:00January 15th, 2020|Tags: , , , |

NuVasive appoints Matthew K Harbaugh as chief financial officer

Matthew K Harbaugh has been appointed as executive vice president and chief financial officer (CFO) of NuVasive. Harbaugh succeeds Rajesh (Raj) J Asarpota, who will transition from the company. A press release reports that Harbaugh brings more than 25 years of experience in finance, business and strategy, and operations management. As CFO, Mr. Harbaugh [...]

2020-01-03T11:43:57+00:00January 3rd, 2020|Tags: , , |

Jean-Claude Dubacher named chairman and CEO of B Braun Medical

Jean-Claude Dubacher B Braun has announced the appointment of Jean-Claude Dubacher as chairman and CEO. Dubacher joined B Braun on 1 August 2019 as president, B Braun Medical. A press release reports that Dubacher’s experience in the healthcare industry spans more than 15 years in consulting and corporate roles, including strategy, commercial, [...]

2020-01-03T11:36:49+00:00January 3rd, 2020|Tags: , |

Fujifilm to acquire Hitachi’s diagnostic imaging-related business

Fujifilm has entered into an agreement with Hitachi to acquire the latter’s diagnostic imaging-related business to further expand its Healthcare business. Prior to the acquisition, Hitachi will establish a company and implement an absorption-type company split whereby the new company will absorb the business. Under the share purchase agreement between Fujifilm and Hitachi, according [...]

2020-01-03T11:30:34+00:00January 3rd, 2020|Tags: , , |

Guerbet appoints David Hale as new CEO

David Hale Guerbet’s Board of Directors has announced that David Hale has been appointed as the company’s CEO. According to a press release, chief commercial officer and group executive committee member since February 2018, David Hale takes over the position from Yves L’Epine, who has been CEO since end of 2011. For [...]

2020-01-03T11:24:48+00:00January 3rd, 2020|Tags: , |

ControlRad announces several additions to its leadership team

Peter Pizzo ControlRad, which is focused on reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), has announced several additions to its leadership team. Joining are Peter Pizzo as chief financial officer, Amy Lazarus as vice president of USA operations, Joe Ross as vice president of marketing, and Sean Finnerty and Tim [...]

2019-12-17T17:10:16+00:00December 17th, 2019|Tags: , |

European Innovation Council (EIC) accelerator programme grant FEops €3.2m

The FEops team FEops has been awarded a grant of €3.2m from the European Innovation Council (EIC) accelerator programme. The grant, a press release reports, will accelerate the clinical evidence gathering and business implementation of FEops HEARTguide predictive preoperative planning for transcatheter structural heart interventions on a worldwide scale. According to the [...]

2019-12-16T14:34:27+00:00December 16th, 2019|Tags: , , , |

Imperative Care announces $85m Series C Financing for stroke treatments

Imperative Care has completed the initial closing of a Series C financing of $85m to support the commercial launch of its portfolio, which is composed of the latest advances in neurovascular devices treating ischaemic and haemorrhagic strokes. The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. A press [...]

2019-12-16T14:19:16+00:00December 16th, 2019|Tags: , , |

Philips and Paige team up to bring AI to clinical pathology diagnostics

Philips and Paige have announced a strategic collaboration to deliver clinical-grade artificial intelligence (AI) applications to pathology laboratories. These AI technologies, starting with Paige Prostate, aim to help pathologists identify, quantify and characterise cancer in tissue samples and make precise diagnoses more efficiently. This may, ultimately, positively impact pathologist’s workflow and treatment planning for [...]

2019-12-09T13:22:50+00:00December 9th, 2019|Tags: , , , , , |

Peregrine Ventures brings total managed funds and co-invest capital to $400 Million

Eyal Lifschitz Peregrine Ventures just closed its fourth fund—Peregrine 4—raising $115 million. Their partners include some of the leading institutional and private equity investors from Israel, the USA, Europe and Australia. According to a press release, Peregrine now has more than $200 million under management and has an equal amount available for [...]

2019-12-09T13:10:06+00:00December 9th, 2019|Tags: , |

InnovHeart appoints Brent Ratz as independent member of the board

InnovHeart—a developer of novel transcatheter mitral valve replacement (TMVR) systems—has appointed medical device entrepreneur J Brent Ratz as non-executive independent member of its Board of Directors. A press release reports that Ratz has more than 19 years of experience in the medical device industry.  He is currently co-founder and managing director of inQB8 Medical [...]

2019-12-06T15:13:06+00:00December 6th, 2019|Tags: , , |

Affidea and GE Healthcare sign a $100 million technology partnership agreement

GE Healthcare and Affidea have signed a multiyear agreement to deploy imaging and digital technologies across the Affidea network. According to a press release, GE Healthcare will install 200+ new equipment in Affidea’s network of centres across Europe. The press release states that the deal includes the provision of 60 new MRIs, 50 ultrasound [...]

2019-12-06T14:54:46+00:00December 6th, 2019|Tags: , , |

Novartis to buy The Medicines Company for $9.7 billion

Novartis has entered into an agreement and plan of merger with The Medicines Company to acquire the US-based biopharmaceutical company for $85 per share in cash, valuing the company at approximately $9.7 billion on a fully diluted equity basis. The offer price represents a premium of approximately 41% over The Medicines Company’s 30-day (to [...]

2019-12-09T10:01:30+00:00December 2nd, 2019|Tags: , , , , |

GE Healthcare expands intelligent Health Ecosystem with launch of Edison Developer Program to ease AI adoption

GE Healthcare GE Healthcare has launched the Edison Developer Program with the aim of accelerating the adoption and impact of intelligent applications and developer services across health systems. The programme is based on Edison, GE Healthcare’s intelligence platform, and is designed to help healthcare providers gain easier access to market-ready algorithms and [...]

2019-12-02T12:24:20+00:00December 2nd, 2019|Tags: , , , |

Canon Medical acquires Skope Magnetic Resonance Technologies

Skope Clip-on Camera Canon Medical has concluded a contract to acquire all shares of Skope Magnetic Resonance Technologies. With a unique research and development team, a press release reports, Skope is a company devoted to providing MRI users with unprecedented imaging quality and performance. The acquisition of Skope was completed according to [...]

2019-12-02T12:03:06+00:00December 2nd, 2019|Tags: , , , |

ATEC launch SafeOp Neural InformatiX system

Alphatec Holdings has announced the commercial release of the SafeOp Neural InformatiX system, which has been designed to seamlessly integrate critical neural information into ATEC procedural solutions. The system has been engineered to provide surgeons with actionable information regarding both the location and the health of nerves at risk during surgery. Specifically, the SafeOp [...]

2019-12-02T11:59:25+00:00December 2nd, 2019|Tags: , , , |

Terumo buys Aortica to further grow its vascular graft business

Terumo has decided to acquire Aortica corporation, which is a US-based company dedicated to advancing the science of personalised vascular therapy. Aortica has developed an automated case planning software known as “AortaFit”, which is designed to precisely match fenestrations on an endograft with the unique locations of each individual patient’s branch arteries during fenestrated [...]

2019-11-25T13:14:15+00:00November 25th, 2019|Tags: , , , , , |

Siemens Healthineers markets new Somatom X.cite CT scanner

Somatom X.cite Siemens Healthineers presents its new Somatom X.cite single-source CT scanner, together with the new myExam Companion user guiding system, based on artificial intelligence (AI). According to a press release, the intelligent user guidance system guides the user through the workflow using specific questions. This user interface, and the latest scanner [...]

2019-11-25T13:01:43+00:00November 25th, 2019|Tags: , , , |

LivaNova bow out of transcatheter mitral valve replacement

A press release reports that LivaNova is to discontinue its Caisson transcatheter mitral valve replacement programme and will undertake a restructuring of its heart valve business to improve profitability and ensure business continuity. It adds that LivaNova’s heart valve business line represented nearly $130 million in revenue for full-year 2018 and has experienced a [...]

2019-11-25T12:55:19+00:00November 25th, 2019|Tags: , , , |

Early Christmas present from the European Commission

Richard Houlihan For those involved in the MedTech industry, unless you have been living under a rock, you will know about the new European medical device regulation (MDR). Furthermore, you will know that Eudamed is at the core of the MDR. However, to recap, MDR-Eudamed is where specific medical device economic operators [...]

2019-11-20T12:27:05+00:00November 20th, 2019|Tags: , , |

Robert B Ford to take over as CEO of Abbott next year

Miles D White will be stepping down, after 21 years, as CEO of Abbott on 31 March 2020. According to a press release, White’s tenure is the second longest for a non-founder in today’s S&P 100; he will remain executive chairman of the Board. The Board has unanimously appointed Robert B Ford—a 23-year Abbott [...]

2019-11-20T12:12:41+00:00November 20th, 2019|Tags: , |

InVivo Therapeutics appoints Robert Rosenthal to Board of Directors

InVivo Therapeutics has appointed Robert J Rosenthal to the company’s Board of Directors, effective 8 November 2019. According to a press release, Rosenthal brings more than 25 years of experience to the InVivo Board as an accomplished executive and business leader in the biotechnology, therapeutics and medical device industries. With the addition of Rosenthal, [...]

2019-11-20T11:56:35+00:00November 20th, 2019|Tags: , |

Google enter definitive agreement to buy Fitbit

Fitbit has entered into a definitive agreement to be acquired by Google for $7.35 per share in cash, valuing the company at a fully diluted equity value of approximately $2.1 billion. A press release reports that Fitbit pioneered the wearables category by delivering innovative, affordable and engaging devices and services. It adds that Fitbit [...]

2019-11-11T14:37:18+00:00November 11th, 2019|Tags: , , , |

Life Spine agrees to pay US government $5.5million over historical shortcomings in compliance programme

Life Spine has entered into a settlement agreement with the USA government that successfully resolves all of the government’s claims. As part of the agreement, it will pay $5.5 million to the US government which noted historical shortcomings in its compliance programme. A press release reports that the company has made significant progress formalising [...]

2019-11-11T14:13:12+00:00November 11th, 2019|Tags: , |

US Patent No 10,463,486 issued for Valfix Medical

Valfix Medical has announced the issuance of US Patent No. 10,463,486 (5 November 2019). According to a press release, this is the second US patent granted for Valfix and was approved only two years and nine months since its priority date. This new patent provides an additional layer of protection for Valfix’s transcatheter repair [...]

2019-11-11T14:01:36+00:00November 11th, 2019|Tags: , |

AliveCor and Huami announce a “multi-faceted global strategic alliance”

KardiaMobile AliveCor and Huami have come together to create a multi-faceted global strategic alliance, according to a press release, that combines the technologies of each company to deliver a new generation of medical functionality to wearable devices. The press release reports that the agreement encompasses the licensing of AliveCor technology and an [...]

2019-11-05T10:34:51+00:00November 4th, 2019|Tags: , , , |

“Collaboration and innovation” is at core of Michael Jaff’s new role at Boston Scientific

Michael Jaff Boston Scientific recently announced that vascular medicine specialist Michael R Jaff (Newton-Wellesley Hospital, Newton, USA) will be joining the company as vice president, clinical affairs, innovation and technology, peripheral interventions. His role will involve, according to Boston Scientific, leading clinical and medical affairs strategies to support the development and commercialisation [...]

2019-11-04T14:47:17+00:00November 4th, 2019|Tags: , , |

Siemens Healthineers completes its acquisition of robotics company Corindus

CorPath GRX As of 29 October 2019, Siemens Healthineers now owns Corindus Vascular Robotics—developer of a robot-assisted system (CorPath) for interventional coronary and vascular procedures. A press release reports that, prior to the closing of the acquisition, 87.5% of Corindus’ stakeholders approved the purchase. It adds that the company is now part [...]

2019-11-07T14:13:56+00:00October 29th, 2019|Tags: , , , |

Venarum Medical receives ongoing NIH SBIR grant for its endovenous valve system

Venarum Medical is in receipt of a mentorship grant in further support of its awarded Phase II SBIR Grant “EVVS: EndoVenous Valve System” currently underway. Under its Phase II work, Venarum proposes to verify the preclinical safety of the endovenous valve system (EVVS). A press release reports that the valve system is a novel [...]

2019-10-28T16:28:14+00:00October 28th, 2019|Tags: , , |

AI stroke care company Viz.ai raises $50 million in Series B round funding

Viz.ai, who is developing the first synchronised healthcare software (Viz) using artificial intelligence (AI), has announced a $50 million Series B funding. A press release reports that the funding round was led by Greenoaks with participation from Threshold Ventures, CRV along with existing investors GV and Kleiner Perkins. The press release adds that Viz.ai [...]

2019-11-07T17:06:00+00:00October 28th, 2019|Tags: , |

Michael C Greiner to step down as CFO of AngioDynamics

A press release reports that the Michael C Greiner, executive vice president and chief financial officer (CFO), of AngioDynamics will be departing the company. It adds that Stephen A Trowbridge—senior vice president and general counsel—will assume the role of interim Chief Financial Officer in addition to his current responsibilities. Greiner will remain with AngioDynamics [...]

2019-10-24T14:03:54+00:00October 24th, 2019|Tags: , |

Michael J McNulty is appointed as vice president of sales and marketing of Miach Orthopaedics

Mike McNulty Miach Orthopaedics has announced that Michael J McNulty has joined the company as vice president of sales and marketing. According to a press release, McNulty will lead Miach’s commercialisation and sales efforts for the Bridge-Enhanced ACL Repair (BEAR) Implant—an investigational device designed for anterior cruciate ligament repair. McNulty brings more [...]

2019-10-21T14:30:05+00:00October 21st, 2019|Tags: , |

Lack of financing prompt Titan Medical to withdraw forecasts relating to its robotic system

Titan Medical is withdrawing all forecasts with respect to the cost and timing of the development of its robotic surgical system beyond the fourth quarter of 2019 because its lack of financing has caused its primary product development supplier to limit the development work on its robotic surgical system. This supplier has also terminated [...]

2019-10-21T14:05:58+00:00October 21st, 2019|Tags: , , |

Michael Jaff joins Boston Scientific to drive innovation in peripheral technologies

Michael Jaff Michael R Jaff is to be vice president, clinical affairs, innovation and technology, peripheral interventions of Boston Scientific by January 2020. In this role, a press release reports, Jaff will lead clinical and medical affairs strategies to support the development and commercialisation of the company’s peripheral vascular medical device portfolio, [...]

2019-10-21T13:48:15+00:00October 16th, 2019|Tags: , |

Admedus sells distribution rights of CardioCel and Vascucel to focus on TAVI programme

CardioCel Admedus has sold its CardioCel and VascuCel patch business to US-based LeMaitre Vascular for up to $A36.2M ($A22.8M upfront) in cash payments. A press release reports that these products originated from the Admedus’s proprietary, regenerative bioscaffold platform technology and are used to address multiple cardiovascular procedures and repairs. The company’s CEO, [...]

2019-10-15T13:50:18+00:00October 15th, 2019|Tags: , , |

Guerbet signs an agreement with icometrix for the exclusive distribution of AI imaging solution icobrain

Guerbet has signed an exclusive agreement with icometrix for the distribution in France, Italy and Brazil of icobrain, their Saas (software as a service) artificial intelligence (AI) based medical imaging solution. According to a press release, icobrain is designed to help radiologists and neurologists diagnose and monitor patients with neurological disorders. The AI software [...]

2019-10-15T13:33:17+00:00October 15th, 2019|Tags: , , , , |

Endotronix closes expanded Series D financing round of $70 Million

Cordella system Endotronix has announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The expansion syndicate for the LSP-led round includes new investment from an additional unnamed medical device strategic investor as well as participation from existing investors, including Aperture Venture Partners, BioVentures [...]

2019-10-09T15:31:42+00:00October 9th, 2019|Tags: , , |

ControlRad secures $15 Million Series B financing

ControlRad has completed $15 million in financing and has added Ryan Drant and Tim Patrick have to its board of directors. The Series B round, which was led by Questa Capital, will be used for fuelling the commercial launch of the innovative ControlRad Trace system.  A press release reports that ControlRad Trace is the [...]

2019-10-09T15:25:55+00:00October 9th, 2019|Tags: , |

Eko secures $20 million in Series B funding

Eko has secured $20 million in Series B funding. Led by ARTIS Ventures, according to a press release, the funding will drive further research and development and commercialisation of Eko’s machine learning platform for cardiac screening and analysis. Additional new and returning investors in the round include DigiTx Partners, NTT Venture Capital (NTTVC), 3M [...]

2019-09-26T15:26:56+00:00September 26th, 2019|Tags: , , |

Viz.ai named as one of Forbes’ most promising AI companies in the USA

Viz.ai has been recognised in the inaugural Forbes AI list as one of the USA’s 50 most promising artificial intelligence (AI) companies. The company uses AI to synchronize stroke care, with the aim of reducing time to treatment and expanding patient access to life-saving care. The Forbes AI list highlights the most promising private [...]

2019-09-20T15:59:44+00:00September 20th, 2019|Tags: , , |

RHYTHM AI successfully closes seed financing round

STAR Mapping RHYTHM AI has announced the closure of a £2.15 million seed financing round. The round was led by an affiliate of Rinkelberg Capital, a private wealth management firm based in London, and was supported by investment from founders. The proceeds will fund a multicentre study of STAR Mapping to improve [...]

2019-09-20T13:46:57+00:00September 20th, 2019|Tags: , , |

CroíValve secures additional €4M funding to evaluate tricuspid therapies

CroíValve has secured €4 million in additional financing, which includes €2.5 million from the European Union (EU) under their Horizon 2020 SME Instrument grant and €1.5 million from Broadview Ventures and current investors (HBAN MedTech and Irrus Syndicates, Atlantic Bridge University Fund and SOSV Ventures). The funding will accelerate the development of the company’s [...]

2019-09-20T13:49:16+00:00September 20th, 2019|Tags: , |

Stereotaxis appoints Kimberly Peery as chief financial officer

Stereotaxis has appointed Kimberly Peery as chief financial officer, effective 1 October 2019. Martin Stammer, who has served as chief financial officer (CFO) since 2013, has accepted a position as the CFO of a large professional services firm headquartered in the St Louis area (USA) and will resign from the Stereotaxis, effective 30 September [...]

2019-09-17T16:06:11+00:00September 17th, 2019|Tags: , |

CroíValve secures additional €4M funding to evaluate tricuspid therapies

CroíValve has secured €4 million in additional financing, which includes €2.5 million from the European Union (EU) under their Horizon 2020 SME Instrument grant and €1.5 million from Broadview Ventures and current investors (HBAN MedTech and Irrus Syndicates, Atlantic Bridge University Fund and SOSV Ventures). The funding will accelerate the development of the company’s [...]

2019-09-17T14:55:26+00:00September 17th, 2019|Tags: , |

AtriCure agrees to buy LARIAT developer SentreHEART

LARIAT AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial fibrillation. A press release reports that the transaction consideration consists of an upfront payment of approximately US$40 million in cash and AtriCure common stock, plus additional contingent [...]

2019-09-16T15:38:00+00:00September 16th, 2019|Tags: , , , |

Stryker announces definitive agreement to acquire Mobius Imaging & Cardan Robotics

Stryker has announced a definitive agreement to acquire Mobius Imaging and its sister company, GYS Tech (DBA Cardan Robotics) in an all cash transaction of approximately $370 million upfront and up to $130 million of contingent payments associated with development and commercial milestones. The acquisition, a press release reports, provides Stryker’s Spine division with [...]

2019-09-06T17:24:56+00:00September 6th, 2019|Tags: , , , |

Andrew Mullen appointed to board of directors of Creavo Medical Technologies

Andrew Mullen Medical device company Creavo Medical Technologies has appointed its operations director Andrew Mullen to its Board of Directors, which will see him lead on research and development (R&D) and regulatory affairs. A press release reports that Mullen has held the operator directors at Creavo for over a year, where he [...]

2019-09-06T17:20:43+00:00September 6th, 2019|Tags: , , |

Robocath raises €5 million ($5.5M) to support the rollout of its robotic platform in strategic European target markets

Lucien Goffart Robocath, which is developing and commercialising cardiovascular robotic systems (such as R-One) for the treatment of vascular diseases, has raised €5 million ($5.5M) to support the roll out of its robotic platform in strategic European target markets. It has also hired Lucien Goffart as CEO. The €5 million ($5.5M) capital [...]

2019-09-06T17:12:04+00:00September 6th, 2019|Tags: , , |

Omar Ishrak to step down as Medtronic CEO next year

Omar Ishrak Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, following the end of the company’s current fiscal year. Also, the Medtronic Board of Directors has announced key leadership appointments as part of its multi-year, leadership succession planning process. A press release reports that these announcements will [...]

2019-09-03T08:16:39+00:00August 30th, 2019|Tags: , |

Delaware Chancery Court rules in favour of Alphatec CEO Pat Miles

Alphatec (ATEC) has announced today that the Delaware Chancery Court entered summary judgment in favour of its chairman and CEO, Pat Miles—terminating all non-competition and employee non-solicitation claims brought against Miles and Atec by NuVasive. According to a press release, Miles joined ATEC as its executive chairman on 2 October 2017, and assumed the [...]

2019-08-27T15:00:13+00:00August 27th, 2019|Tags: , , , |

Varian completes purchase from Boston Scientific

Varian has completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumours. According to a press release, this acquisition expands the portfolio of Varian interventional oncology solutions. Back in July, Varian revealed it had signed an asset purchase agreement to [...]

2019-08-27T15:00:50+00:00August 27th, 2019|Tags: , , , |
Go to Top